Optinose Reports Third Quarter 2022 Financial Results and Operational Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Optinose (OPTN) PT Lowered to $5 at BMO Capital
November 11, 2022 8:53 AM ESTBMO Capital analyst Gary Nachman lowered the price target on Optinose (NASDAQ: OPTN) to $5.00 (from $6.00) while maintaining an Outperform rating.
The analyst commented, "3Q Xhance rev. missed by $3mm, but OPTN managed expenses offsetting that for in-line EPS. Xhance is facing some NT... More
OptiNose (OPTN) Tops Q3 EPS by 1c
November 10, 2022 7:56 AM ESTOptiNose (NASDAQ: OPTN) reported Q3 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $23.55 million.
GUIDANCE:
OptiNose sees Q4 2022 revenue of $74-78 million.
For earnings history and earnings-related data on OptiNose (OPTN) click here.
... More


